Oric Pharmaceuticals Files 2025 Proxy Statement
Ticker: ORIC · Form: DEF 14A · Filed: Apr 23, 2025 · CIK: 1796280
| Field | Detail |
|---|---|
| Company | Oric Pharmaceuticals, Inc. (ORIC) |
| Form Type | DEF 14A |
| Filed Date | Apr 23, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, regulatory-filing, governance
TL;DR
ORIC proxy statement filed. Get ready to vote.
AI Summary
Oric Pharmaceuticals, Inc. filed its definitive proxy statement (DEF 14A) on April 23, 2025, for the fiscal year ending December 31, 2024. The filing pertains to the company's annual meeting and related matters, as required by the Securities Exchange Act of 1934. Oric Pharmaceuticals is a biopharmaceutical company focused on developing therapies.
Why It Matters
This filing provides shareholders with essential information regarding corporate governance and voting matters, allowing them to make informed decisions at the upcoming annual meeting.
Risk Assessment
Risk Level: low — This is a routine regulatory filing (DEF 14A) that provides information to shareholders and does not contain new material financial or operational news.
Key Numbers
- 2024-12-31 — Fiscal Year End (The period covered by the proxy statement's financial reporting.)
- 20250423 — Filing Date (The date Oric Pharmaceuticals submitted this definitive proxy statement to the SEC.)
Key Players & Entities
- Oric Pharmaceuticals, Inc. (company) — Registrant
- 0001796280 (company) — Central Index Key
- 20250423 (date) — Filing Date
- 2024-12-31 (date) — Fiscal Year End
FAQ
What is the purpose of a DEF 14A filing?
A DEF 14A filing, also known as a definitive proxy statement, is used by companies to solicit shareholder votes for their annual meetings and provides detailed information on matters to be voted upon, including director elections and executive compensation.
When is Oric Pharmaceuticals' fiscal year end?
Oric Pharmaceuticals' fiscal year ends on December 31st, as indicated in the filing.
What is the filing date of this DEF 14A?
This definitive proxy statement was filed on April 23, 2025.
What is the Central Index Key (CIK) for Oric Pharmaceuticals?
The Central Index Key for Oric Pharmaceuticals, Inc. is 0001796280.
What is the SIC code for Oric Pharmaceuticals?
The Standard Industrial Classification (SIC) code for Oric Pharmaceuticals is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 23, 2025 regarding Oric Pharmaceuticals, Inc. (ORIC).